Philips will sell its emergency care business to investment firm Bridgefield Capital for an undisclosed amount. The deal is ...

More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent defibrillation dose, while at the same time, minimizing side effects that may be harmful ...

The Philips HeartStart OnSite Defibrillator is designed to be the easiest-to-use, and most reliable defibrillator available. Available without a prescription from ActiveForever.com, the Philips ...

Bridgefield Capital to acquire Royal Philips' emergency care business, expanding its presence in the $26 billion market. Transaction expected to close in 2025.

Philips is parting ways with its worldwide emergency care business, including its catalog of automated external ...

The deal includes a licensing agreement that allows the sold business to use the Philips brand for up to 15 years.

With nearly 40 years of experience in Advanced Life Support (ALS) technologies, starting with the CodeMaster series of defibrillator monitors, Philips has built a legacy of trust, innovation ...

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, ...

Philips’ emergency care business includes cardiac resuscitation devices, such as automated external defibrillators ... outlined image-guided therapy, monitoring, ultrasound, personal health ...